Maravai LifeSciences Stock News
$2.69
0.74%
day before yesterday
Nasdaq,
Jul 25, 10:00 pm CET
Index
Industry
Maravai LifeSciences Stock News
Neutral
GlobeNewsWire
●
5 days ago
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options
Neutral
GlobeNewsWire
●
13 days ago
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options
Neutral
GlobeNewsWire
●
19 days ago
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) on behalf of long-term stockholders following a class action complaint that was filed against Maravai on March 3, 2025 with a Class Period from August 7, 2024 and February 24, 20...
Neutral
GlobeNewsWire
●
25 days ago
SAN DIEGO, July 02, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Quantum Computing Inc. (NASDAQ: QUBT), AppLovin Corporation (NASDAQ: APP), Skyworks Solutions, Inc. (NASDAQ: SWKS), and Maravai LifeSciences Holdings Inc. (NASDAQ: MR...
Neutral
GlobeNewsWire
●
about one month ago
SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh “Raj” Asarpota has been appointed Executive Vice President (EVP) and Chief Financial Officer (CFO), effective June 30, 2025. He will succeed Kevin Herde, who is transitioning to...
Neutral
GlobeNewsWire
●
about one month ago
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) on behalf of long-term stockholders following a class action complaint that was filed against Maravai on March 3, 2025 with a Class Period from August 7, 2024 and February 24, 20...
Neutral
GlobeNewsWire
●
2 months ago
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth
Neutral
GlobeNewsWire
●
2 months ago
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
